NCT03462290View on ClinicalTrials.gov

Botox Injections for Patients With Persistent Facial Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

November 23, 2021

Study Completion Date

November 23, 2021

Conditions
Facial Pain
Interventions
DRUG

botulinum toxin type A

Botulinum toxin type A, powder for solution, 25 international units (IU), injected towards the sphenopalatine ganglion using MultiGuide

DRUG

placebo

solution without botulinum toxin A, injected towards the sphenopalatine ganglion using MultiGuide

Trial Locations (1)

Unknown

Department of Neuroscience, Faculty of Medicine and Health Science, NTNU, Trondheim

All Listed Sponsors
collaborator

St. Olavs Hospital

OTHER

lead

Norwegian University of Science and Technology

OTHER

NCT03462290 - Botox Injections for Patients With Persistent Facial Pain | Biotech Hunter | Biotech Hunter